Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
Abstract The effect of capric acid, secreted by the probiotic yeasts Saccharomyces boulardii, was evaluated on the activities of fluconazole (FLC) and amphotericin B (AMB) against pathogenic Candida albicans fungus. The findings indicated that capric acid may be a promising additive for use in combi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-86012-9 |
id |
doaj-cb82ebae75d74fe2a63e0208428fe095 |
---|---|
record_format |
Article |
spelling |
doaj-cb82ebae75d74fe2a63e0208428fe0952021-03-28T11:32:50ZengNature Publishing GroupScientific Reports2045-23222021-03-0111111010.1038/s41598-021-86012-9Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin BJakub Suchodolski0Daria Derkacz1Przemysław Bernat2Anna Krasowska3Department of Biotransformation, Faculty of Biotechnology, University of WroclawDepartment of Biotransformation, Faculty of Biotechnology, University of WroclawDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of ŁódźDepartment of Biotransformation, Faculty of Biotechnology, University of WroclawAbstract The effect of capric acid, secreted by the probiotic yeasts Saccharomyces boulardii, was evaluated on the activities of fluconazole (FLC) and amphotericin B (AMB) against pathogenic Candida albicans fungus. The findings indicated that capric acid may be a promising additive for use in combination with FLC. A FLC-capric acid combination led to reduced efflux activity of multidrug resistance (MDR) transporter Cdr1p by causing it to relocalize from the plasma membrane (PM) to the interior of the cell. The above effect occurred due to inhibitory effect of FLC-capric acid combination of ergosterol biosynthesis. However, capric acid alone stimulated ergosterol production in C. albicans, which in turn generated cross resistance towards AMB and inhibited its action (PM permeabilization and cytoplasm leakage) against C. albicans cells. This concluded that AMB should not be administered among dietary supplements containing capric acid or S. boulardii cells.https://doi.org/10.1038/s41598-021-86012-9 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jakub Suchodolski Daria Derkacz Przemysław Bernat Anna Krasowska |
spellingShingle |
Jakub Suchodolski Daria Derkacz Przemysław Bernat Anna Krasowska Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B Scientific Reports |
author_facet |
Jakub Suchodolski Daria Derkacz Przemysław Bernat Anna Krasowska |
author_sort |
Jakub Suchodolski |
title |
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B |
title_short |
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B |
title_full |
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B |
title_fullStr |
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B |
title_full_unstemmed |
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B |
title_sort |
capric acid secreted by saccharomyces boulardii influences the susceptibility of candida albicans to fluconazole and amphotericin b |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2021-03-01 |
description |
Abstract The effect of capric acid, secreted by the probiotic yeasts Saccharomyces boulardii, was evaluated on the activities of fluconazole (FLC) and amphotericin B (AMB) against pathogenic Candida albicans fungus. The findings indicated that capric acid may be a promising additive for use in combination with FLC. A FLC-capric acid combination led to reduced efflux activity of multidrug resistance (MDR) transporter Cdr1p by causing it to relocalize from the plasma membrane (PM) to the interior of the cell. The above effect occurred due to inhibitory effect of FLC-capric acid combination of ergosterol biosynthesis. However, capric acid alone stimulated ergosterol production in C. albicans, which in turn generated cross resistance towards AMB and inhibited its action (PM permeabilization and cytoplasm leakage) against C. albicans cells. This concluded that AMB should not be administered among dietary supplements containing capric acid or S. boulardii cells. |
url |
https://doi.org/10.1038/s41598-021-86012-9 |
work_keys_str_mv |
AT jakubsuchodolski capricacidsecretedbysaccharomycesboulardiiinfluencesthesusceptibilityofcandidaalbicanstofluconazoleandamphotericinb AT dariaderkacz capricacidsecretedbysaccharomycesboulardiiinfluencesthesusceptibilityofcandidaalbicanstofluconazoleandamphotericinb AT przemysławbernat capricacidsecretedbysaccharomycesboulardiiinfluencesthesusceptibilityofcandidaalbicanstofluconazoleandamphotericinb AT annakrasowska capricacidsecretedbysaccharomycesboulardiiinfluencesthesusceptibilityofcandidaalbicanstofluconazoleandamphotericinb |
_version_ |
1724199901702651904 |